首页> 外国专利> AZD3355 (LESOGABERAN) FOR TREATMENT AND PREVENTION OF NONALCOHOLIC STEATOHEPATITIS (NASH), LIVER FIBROSIS, AND OTHER LIVER CONDITIONS

AZD3355 (LESOGABERAN) FOR TREATMENT AND PREVENTION OF NONALCOHOLIC STEATOHEPATITIS (NASH), LIVER FIBROSIS, AND OTHER LIVER CONDITIONS

机译:AZD3355(莱索非宾),用于治疗和预防非酒精性脂肪肝(NASH),肝纤维化和其他肝病

摘要

The present invention relates to methods of treatment or prevention of fatty liver disease, nonalcoholic fatty liver disease (NAFLD) including nonalcoholic steatohepatitis (NASH), cirrhosis, liver fibrosis, hepatocellular carcinoma and related liver disease and conditions by administering an effective amount of a GABAB agonist, lesogaberan (AZD3355), or related compounds.
机译:本发明涉及通过施用有效量的GABA来治疗或预防脂肪肝疾病,包括非酒精性脂肪性肝炎(NASH)的非酒精性脂肪肝疾病(NAFLD),肝硬化,肝纤维化,肝细胞癌和相关肝病和病症的方法。 B 激动剂,莱斯加贝兰(AZD3355)或相关化合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号